The G-protein coupled receptors (GPCR) market is projected to grow from USD 4.38 billion in 2026 to USD 7.02 billion by 2034, at a CAGR of 6.07%. This growth is driven by their crucial role in drug discovery for various diseases, increasing investments in pharmaceutical R&D, and advancements in technology such as high-throughput screening. North America currently leads the market, while the Asia Pacific region is expected to see the fastest growth, encouraged by improved research infrastructure. Key trends include the rise of GPCR-targeting therapeutic antibodies and a focus on untapped orphan GPCRs. However, challenges like high R&D costs and supply chain fragility could hinder growth. Companies in this space include established players like Pfizer and emerging biotech firms leveraging AI for drug discovery.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://straitsresearch.com/report/g-protein-coupled-receptors-market
